Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial

AIM: To assess the effects of once‐weekly exenatide on 24‐hour glucose control and variability. MATERIALS AND METHODS: This double‐blind, placebo‐controlled trial randomized metformin‐treated adults with type 2 diabetes to once‐weekly exenatide 2.0 mg or placebo. Continuous glucose monitoring (CGM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Frías, Juan P., Nakhle, Samer, Ruggles, James A., Zhuplatov, Sergey, Klein, Eric, Zhou, Rong, Strange, Poul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168745/
https://www.ncbi.nlm.nih.gov/pubmed/27527911
http://dx.doi.org/10.1111/dom.12763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168745/
https://www.ncbi.nlm.nih.gov/pubmed/27527911
http://dx.doi.org/10.1111/dom.12763

Ejemplares similares